Newsroom | 3187 results

NEW YORK--(BUSINESS WIRE)--BARK, Inc. (“BARK” or the “Company”) (NYSE: BARK), a leading global omnichannel dog brand with the mission to make all dogs happy, announced today that the New York Stock Exchange (the “NYSE”) issued a notice (the “Notice”) on July 10, 2025 informing the Company that it is no longer in compliance with its continued listing standards set forth in Section 802.01C (the “Minimum Stock Price Standard”) because the average closing price of the Company’s common stock was les...

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA) (“Central”), a leading company in the pet and garden industries, today announced that it has raised its outlook for fiscal 2025 non-GAAP earnings per share (EPS) to approximately $2.60. “Fiscal 2025 is tracking ahead of our expectations, reflecting disciplined execution across Team Central,” said Niko Lahanas, CEO of Central Garden & Pet. “Margin expansion is being driven by our Cost and S...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) approval of BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) – a new, once-yearly1 injectable product to treat and protect dogs from fleas and ticks. The product is expected to be available at veterinary clinics and hospitals n...

SAN MATEO, Calif.--(BUSINESS WIRE)--Calysta, the global leader in large-scale cultured protein, has published new peer-reviewed research confirming that FeedKind Pet protein is a safe, highly digestible ingredient for adult dogs with promising early signs of supporting gut health. Published in the journal Animals, the eight-month target animal safety study was designed under FDA Center for Veterinary Medicine guidelines and supports Calysta’s planned GRAS notification for the US market. Thirty-...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Joseph L. (Jay) Hooley to the Company's Board of Directors, effective July 10, 2025. "We are excited to welcome Jay to the IDEXX Board of Directors," said Lawrence D. Kingsley, the Company's Independent Non-Executive Board Chair. “Jay is an accomplished executive who brings extensive strategic thinking and financial leadership experience, alon...

AUSTIN--(BUSINESS WIRE)--Pet Honesty® launches Fresh Breath Dental Bites—the only clean-label, dual-texture dental supplement for cats....

SANTA MONICA, Calif.--(BUSINESS WIRE)--Breakthrough remote-care protocol delivers disease-modifying therapy to feline heart patients nationwide....

LONDRA e PARIGI--(BUSINESS WIRE)--Inspired Pet Nutrition (“IPN”), l'azienda di pet food in più rapida crescita, controllata da CapVest Partners LLP (“CapVest”), e Parquest, azienda leader negli investimenti, hanno accettato i termini dell'acquisizione di Sopral, importante piattaforma di pet food di marca al servizio del mercato europeo, con impianti di produzione in Francia. La transazione è soggetta alle consuete approvazioni normative e alle condizioni di chiusura. I termini finanziari della...

LONDON & PARIS--(BUSINESS WIRE)--Inspired Pet Nutrition („IPN“), das schnell wachsende Unternehmen für Tiernahrung, das von CapVest Partners LLP („CapVest“) kontrolliert wird, und Parquest, eine führende Investmentgesellschaft, haben die Bedingungen für die Übernahme von Sopral vereinbart, einer renommierten Plattform für Marken-Tiernahrung für den europäischen Markt mit Produktionsstätten in Frankreich. Die Transaktion unterliegt den üblichen behördlichen Genehmigungen und Abschlussbedingungen...

LONDRES & PARIS--(BUSINESS WIRE)--Inspired Pet Nutrition (« IPN »), la société d'aliments pour animaux de compagnie à croissance rapide détenue par CapVest Partners LLP (« CapVest »), et Parquest, une société d'investissement de premier plan, ont conclu un accord sur l'acquisition de Sopral, une importante plateforme d'aliments pour animaux de marque desservant le marché européen, dont les activités de production sont basées en France. La transaction est soumise aux approbations réglementaires...